Table 3. Double- and triple-combination... | American Society of Hematology

Table 3.

Double- and triple-combination therapy trials in chronic and advanced phases of myelofibrosis

Double- and triple-combination therapy trials in chronic and advanced phases of myelofibrosis

Double- and triple-combination therapy trials in chronic and advanced phases of myelofibrosis

* Stage 2 of the phase II trial will only evaluate PRM-151 as monotherapy.

This Feature Is Available To Subscribers Only

Sign In or Create an Account